Welcome to Novo Nordisk Science Hub

Are you a healthcare professional?

This is the logo of the provider
ADA 2026 5 - 8 June 2026

Cardiometabolic effects of semaglutide in OASIS 4 participants by body mass index class

Authors :

Rubino Domenica1; Wilson Lauren2; Traina Andrea2; Rathor Naveen3; Wang Julia2; Knight Michael4

Affiliations
View Details Hide Details
Download .PPT Download .PDF
Keywords
Obesity
Congress poster
GLP-1 RA
Semaglutide (oral)
RWE HEOR